Prior Forecasting Accuracy and Investor Reaction to Management Earnings Forecasts
Journal of Financial Reporting · 01.03.2021 · 6 (1) · 87-107
DOI: 10.2308/jfr-2020-005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Financial Reporting, online erschienen am 22.04.2021. Verfasst von Amy P. Hutton und 1 weiteren Autor:innen. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
We examine the properties of firms' forecasting records and whether the accuracy of their prior earnings forecasts affects investor response to their subsequent forecasts.Within the context of a Bayesian model of investor learning, we find that the stock price response to management forecast news is increasing in prior forecast accuracy and also in the length of a firm's forecasting record. Further, we document that investors are more responsive to extreme good and bad news forecasts when a firm has an established forecasting record. Overall, these results suggest that a firm's prior forecasting behavior allows it to establish a forecasting reputation, and that market forces encourage accurate forecasting as firms benefit from having a reputation for forecasting accurately. Data Availability: Data are available from public sources cited in the text. JEL Classifications: G19; G39; D89; M40.
Zitieren
APA
Hutton, A. P., & Stocken, P. C. (2021). Prior Forecasting Accuracy and Investor Reaction to Management Earnings Forecasts. Journal of Financial Reporting, 6(1), 87-107. https://doi.org/10.2308/jfr-2020-005
Vancouver
Hutton AP, Stocken PC. Prior Forecasting Accuracy and Investor Reaction to Management Earnings Forecasts. Journal of Financial Reporting. 2021;6(1):87-107. doi:10.2308/jfr-2020-005
BibTeX
@article{Hutton2021,
author = {Hutton, Amy P. and Stocken, Phillip C.},
title = {Prior Forecasting Accuracy and Investor Reaction to Management Earnings Forecasts},
journal = {Journal of Financial Reporting},
year = {2021},
volume = {6},
number = {1},
pages = {87--107},
doi = {10.2308/jfr-2020-005}
}
EUVIMED